Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor

Archives of Oral Biology

Volumn 56, Issue 3, 2011, Pages 205-211

  Guo, Ling ^a   Wang, Min ^a   Zhang, Zhi Yi ^a   Hao, Liang ^a   Lou, Bei Yan ^a   Li, Xiao Yu ^a   Loo, Wings T Y ^b   Jin, Lijian ^b   Cheung, Mary N B ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin II; Extracellular signal regulated kinase; Interleukin 6; Osteoblast

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; ENZYME ACTIVATION; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; RECEPTOR, ANGIOTENSIN, TYPE 1;

MUS;

EID: 79951855395     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.09.016     Document Type: Article

References (45)

1. D.S. Raj Role of interleukin-6 in the anemia of chronic disease Semin Arthritis Rheum 35 2009 382 388
2. Z. Xing, J. Gauldie, G. Cox, H. Baumann, M. Jordana, and X.F. Lei IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses J Clin Invest 101 1998 311 320 (Pubitemid 28067327)
3. R.E. Lyons, J.P. Anthony, D.J. Ferguson, N. Byrne, J. Alexander, and F. Roberts Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6 Infect Immun 69 2001 2589 2595 (Pubitemid 32239733)
4. T.F.S. Taga Role of IL-6 in the neural stem cell differentiation Clin Rev Allergy Immunol 28 2005 249 256
5. F.A. van de Loo, S. Kuiper, F.H. van Enckevort, O.J. Arntz, and W.B. van den Berg Interleukin-6 reduces cartilage destruction during experimental arthritis - a study in interleukin-6-deficient mice Am J Pathol 151 1997 177 191
6. J. Peltola, J. Laaksonen, A.M. Haapala, M. Hurme, S. Rainesalo, and T. Keränen Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels Seizure 11 2002 44 46 (Pubitemid 34187769)
7. S.M. Algan, M. Purdon, and S.M. Horowitz Role of tumor necrosis factor alpha in particulate-induced bone resorption J Orthop Res 14 1996 30 35 (Pubitemid 26093703)
8. T. Seck, I. Diel, H. Bismar, R. Ziegler, and J. Pfeilschifter Expression of interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women Bone 30 2002 217 222 (Pubitemid 34044319)
9. K. Kayamori, K. Sakamoto, T. Nakashima, H. Takayanagi, K. Morita, and K. Omura Roles of Interleukin-6 and Parathyroid Hormone-Related Peptide in osteoclast formation associated with oral cancers significance of Interleukin-6 synthesized by stromal cells in response to cancer cells Am J Pathol 176 2010 968 980
10. T. Hierl, I. Börcsök, U. Sommer, R. Ziegler, and C. Kasperk Regulation of interleukin-6 expression in human osteoblastic cells in vitro Exp Clin Endocrinol Diabetes 106 1998 324 333 (Pubitemid 28457014)
11. N. Seki, H. Shirasaki, M. Kikuchi, and T. Himi Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells Life Sci 80 2007 1592 1597 (Pubitemid 46412362)
12. C.H. Tsai, S.F. Yang, Y.J. Chen, S.C. Chu, Y.S. Hsieh, and Y.C. Chang Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels Oral Dis 10 2004 360 364
13. M. Yoshida, Y. Kanno, A. Ishisaki, H. Tokuda, K. Hirade, and K. Nakajima Methotrexate suppresses inflammatory agonist induced interleukin 6 synthesis in osteoblasts J Rheumatol 32 2005 787 795 (Pubitemid 40676484)
14. J.C. Dai, P. He, X. Chen, and E.M. Greenfield TNF alpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics Bone 38 2006 509 520
15. C. Patil, X. Zhu, C. Rossa Jr., Y.J. Kim, and K.L. Kirkwood p38 MAPK regulates IL-1 beta induced IL-6 expression through mRNA stability in osteoblasts Immunol Invest 33 2004 213 233 (Pubitemid 38685932)
16. M.M. Knuepfer, K.D. Rowe, J.A. Schwartz, and L.L. Lomax Role of angiotensin II and corticotropin-releasing hormone in hemodynamic responses to cocaine and stress Regul Pept 127 2005 1 10 (Pubitemid 40179236)
17. M. Horiuchi, J.Y. Lehtonen, and L. Daviet Signaling mechanism of the AT2 Angiotensin II receptor: crosstalk between AT1 and AT2 receptors in cell growth Trends Endocrinol Metab 10 1999 391 396
18. Y.Y. Ji, J.T. Liu, N. Liu, Z.D. Wang, and C.H. Liu PPARα activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway Biochem Pharmacol 78 2009 1186 1197
19. Y. Weng, and S.D. Shukla Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence Eur J Pharmacol 398 2000 323 331 (Pubitemid 30349096)
20. R. Kranzhöfer, J. Schmidt, C.A. Pfeiffer, S. Hagl, P. Libby, and W. Kübler Angiotensin induces inflammatory activation of human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 19 1999 1623 1629 (Pubitemid 29323820)
21. K. Tsuchiya, T. Yoshimoto, Y. Hirono, T. Tateno, T. Sugiyama, and Y. Hirata Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes Am J Physiol Metab 291 2006 E771 E778
22. J.M. Proudfoot, K.D. Croft, I.B. Puddey, and L.J. Beilin Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1 J Pharmacol Exp Ther 305 2003 846 853 (Pubitemid 36617960)
23. Y. Nishiya, and S. Sugimoto Effects of various antihypertensive drugs on the function of osteoblast Biol Pharm Bull 24 2001 628 633 (Pubitemid 32586651)
24. E. Gulcan, A. Gulcan, S. Toker, and E. Cosar Are there any effects of angiotensin II receptor blockers on postmenopausal osteoporosis? Med Hypotheses 70 2008 701 702 (Pubitemid 351179923)
25. H. Shimizu, H. Nakagami, M.K. Osako, R. Hanayama, Y. Kunugiza, and T. Kizawa Angiotensin II accelerates osteoporosis by activating osteoclasts FASEB J 22 2008 2465 2475 (Pubitemid 351948664)
26. B. Altun, A.A. Kiykim, V. Seyrantepe, C. Usalan, M. Arici, and M. Calar Association between activated renin angiotensin system and bone formation in hemodialysis patients: is the bone mass genetically determined by ACE gene polymorphism? Ren Fail 26 2004 425 431 (Pubitemid 39167621)
27. M. Wiens, M. Etminan, S.S. Gill, and B. Takkouche Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies J Intern Med 24 2006 581 589
28. L. Rejnmark, P. Vestergaard, and L. Mosekilde Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study J Hypertens 24 2006 581 589 (Pubitemid 43261923)
29. M. Haneda, T. Sugimoto, and R. Kikkawa Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade Eur J Pharmacol 365 1999 1 7 (Pubitemid 29070713)
30. 2+, and cell energetics and the impact of extracellular signal-regulated kinase signaling on apoptosis and necrosis Toxicol Sci 92 2006 464 475 (Pubitemid 44018963)
31. A. Suzuki, G. Palmer, J.P. Bonjour, and J. Caverzasio Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells J Bone Miner Res 15 2000 95 102 (Pubitemid 30026936)
32. J.R. Chen, L.I. Plotkin, J.I. Aguirre, L. Han, R.L. Jilka, and S. Kousteni Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens J Biol Chem 280 2005 4632 4638 (Pubitemid 40288632)
33. T. Koizumi, H. Hikiji, W.S. Shin, T. Takato, S. Fukuda, and T. Abe Cell density and growth-dependent down-regulation of both intracellular calcium responses to agonist stimuli and expression of smooth-surfaced endoplasmic reticulum in MC3T3-E1 osteoblast-like cells J Biol Chem 278 2003 6433 6439 (Pubitemid 36800902)
34. G. Kofla, and M. Ruhnke Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression J Microbiol Methods 68 2007 178 183 (Pubitemid 46054330)
35. A. Tomizawa, Y. Hattori, and K. Kasai Induction of gene expression in response to globular adiponectin in vascular endothelial cells Life Sci 85 2009 457 461
36. L. Hu, Y. Shi, J.H. Hsu, J. Gera, B. Van Ness, and A. Lichtenstein Downstream effectors of oncogenic ras in multiple myeloma cells Blood 101 2002 3126 3135
37. G.R. Mundy Osteoporosis and inflammation Nutr Rev 65 2007 S147 S151
38. M. Harjacek, S. Diaz-Cano, B.A. Alman, J. Coburn, R. Ruthazer, and H. Wolfe Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis J Rheumatol 27 2000 497 503 (Pubitemid 30095487)
39. F. Kawana, and T. Sasaki Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice J Electron Microsc 52 2003 515 525 (Pubitemid 38092539)
40. Y. Takaoka, S. Niwa, and H. Nagai Interleukin-1 beta induces interleukin-6 production through the production of prostaglandin E-2 in human osteoblasts, MG-63 cells J Biochem 126 1999 553 558 (Pubitemid 29452620)
41. T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, and T. Tsutsui Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure J Am Coll Cardiol 35 2000 714 721 (Pubitemid 30167029)
42. M. Ishida, T. Ishida, S.M. Thomas, and B.C. Berk Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells Circ Res 82 1998 7 12 (Pubitemid 28074013)
43. I. Papparella, G. Ceolotto, L. Lenzini, M. Mazzoni, L. Franco, and M. Sartori Angiotensin II-induced over-activation of p47phox in fibroblasts friorn hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II? J Hypertens 23 2005 793 800 (Pubitemid 40523278)
44. A. Kondo, and A. Togari Activation of osteoblastic functions by a mediator of pain, bradykinin Biochem Pharmacol 68 2004 1423 1431 (Pubitemid 39179400)
45. A. Holownia, and J.J. Braszko The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells Naunyn Schmiedebergs Arch Pharmacol 6 2007 157 163 (Pubitemid 350029413)